Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network.
Jennifer Philippon BoothJulie M Kennerly-ShahLindsey R KelleyDonna CapozziHillary A PrescottScott A SoefjeMakala B PaceSally Y BarbourRicky F TizonSarah DeVincenzoCynthia A CarnesMarjorie V NeideckerPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
This Delphi panel of 124 clinical pharmacists achieved consensus on 18 acuity factors that would identify a hematology/oncology patient as a high priority for ambulatory clinical pharmacist review. The research team envisions incorporating these acuity factors into a pharmacy-specific electronic scoring tool.